| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/14/2002 | WO2001059129A3 Mammalian secreted group iii phospholipase a2 |
| 03/14/2002 | WO2001058921A9 Methods and compositions for generating angiostatin |
| 03/14/2002 | WO2001057239A3 Reagent test strip for analyte determination |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001056456A3 Methods and compositions for detection of disease |
| 03/14/2002 | WO2001055715A3 Device and method for detecting the coagulation functions of global, especially primary hemostasis |
| 03/14/2002 | WO2001055691A3 Waveguide plate and sensor platforms based thereon, arrangements of sample containers and detection methods |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055358A3 Phosphodiesterases |
| 03/14/2002 | WO2001054707A3 Modification of surface proteins by aminopeptidase inhibitors |
| 03/14/2002 | WO2001051919A9 High-throughput formation, identification, and analysis of diverse solid-forms |
| 03/14/2002 | WO2001051660A3 Method and kit for diagnosis of neoplastic transformation |
| 03/14/2002 | WO2001051519A3 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | WO2001042508A3 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 03/14/2002 | WO2001040757A3 Resonant optical cavities for high-sensitivity, high-throughput biological sensors and methods |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |
| 03/14/2002 | WO2001036966A3 An apparatus for machine fluid analysis |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001033219A3 Ion channel permeability |
| 03/14/2002 | WO2001032161A3 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 03/14/2002 | WO2001027634A3 Method for determining of autoantibodies against the tsh receptor |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | WO2000074662A3 Arthritis treatment |
| 03/14/2002 | WO2000063441A3 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| 03/14/2002 | WO2000056927A3 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO2000042430A9 Lateral flow test strip |
| 03/14/2002 | WO2000040947A9 Method and apparatus for separating biological materials and other substances |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032912 Detecting modulators of transcriotional activity; obtain genetically engineered cells, expose to modulators, evaluate reporter gene expression |
| 03/14/2002 | US20020032534 Method, device and computer-readable memory containing a computer program for determining at least one property of a test emulsion and/or test suspension |
| 03/14/2002 | US20020032530 Integrated genomic services |
| 03/14/2002 | US20020032410 Tool and appliance for collecting slight amount of humor |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032281 Crosslinked polymeric structure that degrades in aqueous solution and releases into the solution conjugates of a bioactive agent and a substantially nonpeptidic polymer. |
| 03/14/2002 | US20020032272 Nanoporous interpenetrating organic-inorganic networks |
| 03/14/2002 | US20020032200 2-Substituted imidazo[1,2-A]pyridine derivatives |
| 03/14/2002 | US20020032149 Monitoring blood flow parameter of bloodstream, administering substance to organism such that an amount of substance enters bloodstream; distributing portion of amount ofsubstance target within organism |
| 03/14/2002 | US20020032148 Pharmaceutical agent containing Rho kinase inhibitor |
| 03/14/2002 | US20020032112 Blood processing method and apparatus |
| 03/14/2002 | US20020031845 Device for the collection, testing and shipment of body fluid samples |
| 03/14/2002 | US20020031842 Apparatus for use in the analysis and detection of, bacteria, viruses, human hormones, drugs and nucleic acids |
| 03/14/2002 | US20020031840 Method and apparatus for producing visual results using colorimetric strips |
| 03/14/2002 | US20020031839 Method and apparatus for rapid analysis of analytes in biological samples |
| 03/14/2002 | US20020031833 Device for use in generation of preferential libraries |
| 03/14/2002 | US20020031821 Monitoring activity of modulators; provide subtrate, flush fluid through channel, flush modulator theough channel, detect adjustment in activity associated with modulators |
| 03/14/2002 | US20020031819 Screening process for antibacterial agents |
| 03/14/2002 | US20020031818 Modification of Mdm2 activity |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase |
| 03/14/2002 | US20020031796 Using enzyme mixture |
| 03/14/2002 | US20020031793 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 03/14/2002 | US20020031792 Complexing with monoclonal antibodies |
| 03/14/2002 | US20020031791 Whole blood immunoassay |
| 03/14/2002 | US20020031790 Reducing inaccuracy in protein activity; obtain target particles, incubate with probes, monitor and detect binding activity of particles |
| 03/14/2002 | US20020031789 Apparatus for the analysis of cells; obtain sample, insert into container, incubate with test particle, monitor sample |
| 03/14/2002 | US20020031788 Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto |
| 03/14/2002 | US20020031787 Detecting autoimmune disease; obtain blood sample, measure amount of lymphocytes in blood, diagnose autoimmune disease |
| 03/14/2002 | US20020031786 Measurement of analytes in whole blood |
| 03/14/2002 | US20020031785 Splice variants of brca1 and brca2 |
| 03/14/2002 | US20020031781 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/14/2002 | US20020031780 Modulators of polypeptide binding activities; for use in the treatment, prevention of infections and viral disease |
| 03/14/2002 | US20020031775 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 03/14/2002 | US20020031774 Process for aligning macromolecules by passage of a meniscus and applications |
| 03/14/2002 | US20020031768 Method for quantitative analysis of a nucleic acid amplification reaction |
| 03/14/2002 | US20020031767 Diagnosing inflammatory bowel disease; obtain sample, detect preferential gene expression, the presence of preferential gene expression indicates inflammatory bowel disease |
| 03/14/2002 | US20020031766 Designing preferential particles; provide target, mix with ligands, form microarrays, bind target to preferential particle |
| 03/14/2002 | US20020031761 Amino acid sequences for use in the detection and separation of preferential microorganism from samples |
| 03/14/2002 | US20020031760 Nucleotide sequences for use in the detection of preferential microorganism |
| 03/14/2002 | US20020031759 Diagnosing pancreatic defect in humans; obtain organelle sample, detect preferential organelle, monitor sample for organelle defect, diagnose pancreatic defect |
| 03/14/2002 | US20020031758 Aggregating preferential particles; obtain preferential particles, mix in solution, expose to charge, recover aggregates |
| 03/14/2002 | US20020031539 Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| 03/14/2002 | US20020031528 Vaccines containing beta-hexosamine bind with antibodies and carriers |
| 03/14/2002 | US20020031526 Reacting with a base to form a de-n-acetylated product, and depolymerizing with a nitrosation agent |
| 03/14/2002 | US20020031514 Method for induction of differentiation of osteoclasts |
| 03/14/2002 | US20020031510 Contacting B7-positive cell with first soluble ligand which recognizes and binds B7 antigen, and contacting gp39-positive cell with second soluble ligand which recognizes and binds gp39 antigen; inhibiting rejection of transplanted tissues |
| 03/14/2002 | US20020031508 Administering inducer of P-selectin activity such that hemostasis occurs |
| 03/14/2002 | US20020031496 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/14/2002 | US20020031492 Providing a brain tumor sample, quantifying the expression of an interleukin-13 (IL-13) receptor in the sample; and correlating the quantity of expression of the IL-13 receptor with the tumor type or grade; prognosis |
| 03/14/2002 | US20020031477 Biomedical assay device |
| 03/14/2002 | US20020031446 Automatic diagnostic apparatus |
| 03/14/2002 | US20020031445 For use in automatic staining of cytological or histological specimens, comprises running-water station |
| 03/14/2002 | US20020031255 Multi-neural net imaging apparatus and method |
| 03/14/2002 | US20020031165 Aggregate dilatometer device and methods of testing |
| 03/14/2002 | US20020030811 Arrangement for visualizing molecules |
| 03/14/2002 | US20020030009 Membrane and method for making same with consistent wicking properties for lateral flow assays |
| 03/14/2002 | US20020029980 Limiting current type oxygen sensor having oxygen pump cell comprising oxygen ion conductive solid electrolyte and metal electrode |
| 03/14/2002 | US20020029971 Multiplexed active biologic array |
| 03/14/2002 | US20020029969 Substrate with many channels filled with a homogeneous separation matrix which acts as an obstacle to the electrophoretic migration of the charged molecules, using a series of micro-electrodes to move a sample |
| 03/14/2002 | US20020029965 For detecting oxidizable gases such as hydrogen; catalyst disk or low impedance fuel cell between the counterelectrode and protection membrane; allows detection of gases that reach both the working electrode and counterelectrode |
| 03/14/2002 | DE19905493C2 Meßvorrichtung zur reproduzierbaren Bestimmung der Qualität menschlichen Gewebes Measuring device for reproducible determination of the quality of human tissue |
| 03/14/2002 | DE19740429C2 Verfahren zur Entnahme von biologischen Proben A process for the removal of biological samples |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |